Hudson Institute of Medical Research

Site

Hudson Institute Cell Therapies

Accreditation No.

21322

Site No.

25678

Date of Accreditation

04 Oct 2024

Address

TRF, Level 4, 27-31 Wright Street
Clayton, VIC 3168
Australia

hudson.org.au

Contact

Dr Mirja Krause Onwukwe P: +61 (03) 85722802

Availability

Services conditionally available to external clients

Supervision

HPS (Haemopoietic processing, storage)

Scope of Accreditation

Hudson Institute Cell Therapies

ISO 15189 (2022)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProducts received from AN 21171 SN 25469 Haemopoietic progenitor cells Processing; Storage (includes freezing/thawing)

The only data displayed is that deemed relevant and necessary for the clear description of the Activities and Services covered by the Scope of Accreditation (SoA).

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.

The Product column may also describe an Item or Material.

The Limitations column may also describe the Range.